Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[New molecular markers within the chronic myeloproliferative disorders. I: the PRV-1 gene].

Ugeskrift for laeger - 25 Sept 2006

Larsen Thomas Stauffer, Pallisgaard Niels, Christensen Jacob Haaber, Gram-Hansen Paul, Kerndrup Gitte B, Møller Michael Boe, Hasselbalch Hans Carl

Abstract excerpt

PRV-1 is a new molecular marker within the Ph-negative chronic myeloproliferative disorders. PRV-1 is a useful, highly sensitive and specific marker in the differentiation between polycythaemia vera (PV) and secondary erythrocytosis (ET), and seems to identify those PV patients presenting in the early phase of the disease with dominating thrombocytosis and thus a clinical phenotype of ET. These PRV-1 positive ET...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to GPI-Linked Proteins
Share to Isoantigens

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Share to Myeloproliferative Disorders

Share to Philadelphia Chromosome

Share to Polycythemia Vera

Share to Primary Myelofibrosis

Share to Thrombocytosis

Source

Identifiers

PMID: 17032591

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 10 closest

[New molecular markers within the chronic myeloproliferative disorders. I: the PRV-1 gene].PMID 17032591Read ↗

PRV-1 and its correlation with treatments and disease status in 210 patients with polycythemia vera and essential thrombocythemia.Semantic proximity Read ↗

Concomitant neutrophil <i>JAK2</i><sup>V617F</sup> mutation screening and <i>PRV‐1</i> expression analysis in myeloproliferative disorders and secondary polycythaemiaSemantic proximity Read ↗

PRV-1 mRNA expression discriminates two types of essential thrombocythemiaSemantic proximity Read ↗

[Significance of the JAK2V617F mutation in patients with chronic myeloproliferative neoplasia].Semantic proximity Read ↗

Cloning of PRV-1, a novel member of the uPAR receptor superfamily, which is overexpressed in polycythemia rubra veraSemantic proximity Read ↗

[Expression of JAK2V617F and MPLW515L/K mutation in 30 suspected cases of early myeloproliferative disorders].Semantic proximity Read ↗

[Pulmonary Hypertension and Polycythemia vera].Semantic proximity Read ↗

New and old prognostic factors in polycythemia vera.Semantic proximity Read ↗

Biochemical characterization of PRV-1, a novel hematopoietic cell surface receptor, which is overexpressed in polycythemia rubra veraSemantic proximity Read ↗

JAK2 V617F mutation and PRV-1 overexpression: relevance in the diagnosis of polycythaemia vera and essential thrombocythaemia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.